AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 232 min read$ENVA

TEBBE MARK sold $4.0M of ENVA

TEBBE MARK sold 20,000 shares of Enova International, Inc. (ENVA) at $201.37 ($4.03M total) on 2026-06-18.

Original reporting
SEC EDGAR · TEBBE MARK
Published Jun 23, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This is a primary-source disclosure of an insider sale. It can modestly influence short-term sentiment, but it does not introduce new operational, financial, or regulatory information about ENVA.

02

Market read

Traders may monitor whether this sale is part of a broader pattern, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Form 4 sales often have non-informational drivers; without additional context (e.g., repeated sales, size vs. typical activity, or concurrent operational news), the trading signal is weak.

Relevance 6/10Novelty 3/10Timing: after-hours/filing timestamp (2026-06-23) for the 2026-06-18 sale disclosure

Background

SEC Form 4 insider transaction for Enova International, Inc. (ENVA): director TEBBE MARK sold 20,000 shares at $201.3680 on 2026-06-18; filing made 2026-06-23.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova director TEBBE MARK filed a Form 4 selling 20,000 shares at $201.3680 on 2026-06-18, totaling ~$4.03M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by other news.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it provides no new company fundamentals, guidance, or transaction terms beyond the trade size and price.

Market effects

Sector

No clear sector read-through; this is an individual insider transaction without stated company-wide developments.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale could be planned liquidity (even though the filing notes no pre-arranged 10b5-1 plan), personal diversification, or tax-related selling rather than a bearish signal.

Key entities

  • issuer
    Enova International, Inc.

    Company whose director filed the Form 4 insider sale.

  • insider
    TEBBE MARK

    Director who sold 20,000 shares in an open-market transaction.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ENVA insider trading history →

Related articles

SEP 15
$ENVAMedAI 8/10

Enova International subsidiary announces $500 million asset-backed notes offering

Enova International's subsidiary plans a $500M asset-backed notes offering, with four classes of notes ranging from 5.61% to 8.28% interest. The notes are backed by small business loans and expected to be rated by Kroll. Enova reported strong Q2 2026 earnings, exceeding estimates, but withdrew a bank acquisition due to regulatory challenges. Citizens lowered its price target to $215, maintaining an Outperform rating.

uk.investing.com2 min
SEP 15
$ENVAMedAI 8/10

Enova to issue $500.026M Series 2026-1 asset-backed notes backed by OnDeck loans

Enova plans to issue $500.026M in asset-backed notes due 2026, secured by OnDeck small business loans. The notes, divided into four classes, have fixed rates ranging from 5.61% to 8.28%. KBRA is expected to rate the notes AA(sf) to BB(sf). The proceeds will be used to purchase loans from OnDeck and fund a reserve account. The offering is targeted at qualified institutional buyers under Rule 144A and offshore under Regulation S, with a closing date around September 25, 2026, subject to conditions

tradingview.com1 min